- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 73.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 74.09M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 73.5M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $21.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $188K |
| Capex | Q1 2026 · Mar 31, 2025 | $651K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $48.83M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $44.97M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $228.83M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $231.23M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $9.6M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $9.6M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $55.96M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $51.42M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $150.03M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $135.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$58.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$46.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$31.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$32.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $402.66M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $452.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $682.33M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $738.39M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $453.95M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $519.42M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $623.36M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $691.4M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $33.67M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $25.08M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $46.32M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $41.83M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.18M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.16M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$834K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $147.77M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $122.39M |
| Revenue | Q1 2026 · Mar 31, 2026 | $202.18M |
| Revenue | Q1 2026 · Mar 31, 2025 | $166.43M |